RT @OrbiMed: Congratulations to our team and our portfolio company, @boltivl! This morning, @Bostonsci announced the acquisition of Bolt Me…

RT @EVToday: Boston Scientific Announces Acquisition Agreement for Bolt Medical | @bostonsci @boltivl

RT @bostonsci: We’ve agreed to acquire @BoltIVL, developer of an intravascular lithotripsy (IVL) offering to treat coronary and peripheral…

Bolt Medical Announces Completion of The RESTORE ATK and RESTORE BTK Pivotal Studies Investigating the Unique Bolt...

Bolt Medical Announces Results of RESTORE FIH IVUS Coronary Study for the Unique Bolt Intravascular Lithotripsy Sy...

Extending our gratitude to Professor Marianne Brodmann and our team of physician investigators for their contributions to the RESTORE ATK 75-patient cohort presented at the 2024 AMP Conference in Chicago for our New Generation Bolt IVL system. #BoltIVL #CLIFighters #AMPCLI2024

Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular...

Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular... #boltivl #ivl #crackingcalcium

Bolt Medical Announces Results of RESTORE FIH Coronary Feasibility Study for the Unique Bolt Intravascular Lithotr... #boltivl #ivl #cardiotwitter

Share

RT @EVToday: Bolt IVL System’s RESTORE ATK Pivotal Trial Completes Enrollment | @boltivl

Bolt IVL System’s RESTORE ATK Pivotal Trial Completes Enrollment on @EVToday

Introducing new generation IVL to Vascular Specialists @CXSymposium in London. Thank you to Professor Marianne Brodmann for an excellent case review of the laser-based Bolt IVL system #BoltIVL #IVL #CX2024

Bolt Medical Announces Completion of Enrollment of RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lit...